​

Carmell Therapeutics (CTCX) Revenue & Revenue Breakdown

OverviewFinancialsChart

Carmell Therapeutics Revenue Highlights

0

Latest Revenue (Q)

$510.35K

Carmell Therapeutics Revenue by Period

Carmell Therapeutics Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31--

Carmell Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Carmell Therapeutics Revenue by Quarter

DateRevenueChange
2025-03-31$510.35K2819.81%
2024-12-31$17.48K-14.82%
2024-09-30$20.52K66.55%
2024-06-30$12.32K100.00%
2024-03-31--100.00%
2023-12-31$-3.73M-200.00%
2023-09-30$3.73M100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30--

Carmell Therapeutics generated $510.35K in revenue during Q1 2025, up 2819.81% compared to the previous quarter, and up -13.69% compared to the same period a year ago.

CTCX Revenue FAQ

What is Carmell Therapeutics’s yearly revenue?

Carmell Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. CTCX's yearly revenue for 2021 was $0, representing an increase of 0% compared to 2020.

What is Carmell Therapeutics’s quarterly revenue?

Carmell Therapeutics's quarterly revenue for Q1 2025 was $510.35K, a 2819.81% increase from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $17.48K, a -14.82% decrease from the previous quarter (Q3 2024), and a 0% increase year-over-year (Q4 2023). CTCX's quarterly revenue for Q3 2024 was $20.52K, a 66.55% increase from the previous quarter (Q2 2024), and a -99.45% decrease year-over-year (Q3 2023).

What is Carmell Therapeutics’s revenue growth rate?

Carmell Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%